Home
About Us
Seglin Technology
Programmes
Investors
News Centre
Careers
Contact Us
News Centre
Press Releases
Latest
2012
2011
2010
2009
2008
2007
2006
2005
2004
Events
Home
...
News Centre
...
Press Releases
Press Releases
$1.5 million agreement secured with US DMD organisations
Released 19th December 2011
US Orphan Drug Status Granted to SMT C1100 for DMD
Released 24th November 2011
Appointment of Hybridan as Joint Broker
Released 1st November 2011
Exercise of Warrants
Released 27th September 2011
New data from C. difficile programme presented at ICAAC
Released 19th September 2011
Interim results for six months ended 31 July 2011
Released 23rd August 2011
Issue of equity
Released 25th July 2011
Summit present at ICAD 2011
Released 19th July 2011
Positive results to be reported at international Alzheimer's disease conference
Released 30th June 2011
AGM Statement
Released 19th May 2011
Successful achievement of research milestone in C. difficile programme
Released 12th May 2011
Publication of DMD paper in leading scientific journal
Released 5th May 2011
Notice of 2011 Annual General Meeting
Released 15th April 2011
Grant of Options
Released 11th April 2011
Preliminary results
Released 30th March 2011
Research update: Positive results in DMD programme
Released 14th March 2011
